MAIN OBSTETRIC COMPLICATIONS ASSOCIATED WITH ANTIPHOSPHOLIPID SYNDROME (LITERATURE REVIEW)
Keywords:
APS (antiphospholipid syndrome), miscarriage, pregnancy, thromboembolic complicationsAbstract
APS (antiphospholipid syndrome) is a disruption of the body's autoimmune response, manifesting as miscarriages and thromboembolic complications during pregnancy. It is associated with a high risk of obstetric and perinatal complications. It primarily affects blood circulation in the fetoplacental system. Thrombuses formed as a result of autoimmune reactions damage the walls of the endothelium in the entire body, in particular, in the blood vessels, as in the placenta and in the vessels of the trophoblast, which can lead to antenatal fetal death or miscarriage at an early stage of gestation.
References
Meroni P.L. et al. Pathogenesis of the antiphospholipid syndrome: an additional example of the mosaic of autoimmunity // Journal of Autoimmunity. 2018; 30(1-2): 99-103.
Erkan D., et al. Clinical patterns and outcomes in APS patients: multicenter cohort // Arthritis Rheum. — 2019. — Vol. 60, No. 4. — P. 1103–1111.
Hughes G.R. The anticardiolipin antibodies and the antiphospholipid syndrome // Ann. Rheum. Dis. — 2019. — Vol. 49, No. 5. — P. 289–293.
Pierangeli S.S., et al. Animal models of APS: lessons for pathogenesis // J. Thromb. Haemost. — 2017. — Vol. 5, No. 1. — P. 1–9.
Miyakis S., Lockshin M.D., Atsumi T., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome // Journal of Thrombosis and Haemostasis. — 2016. — Vol. 4, No. 2. — P. 295–306.
Galli M., Barbui T. Antiphospholipid antibodies and venous thromboembolism // Semin. Thromb. Hemost. — 2017. — Vol. 33, No. 7. — P. 645–651.
Ruiz-Irastorza G., Hunt B.J., Khamashta M.A. A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies // Arthritis & Rheumatism. — 2017. — Vol. 57, No. 8. — P. 1487–1495.
Negmatullaeva, M. N., Tuksanova, D. I., & Zaripova, D. Y. (2024). Structural-optical properties of blood serum and their role in predicting the development of osteoporosis in perimenopause. Russian Bulletin of Obstetrician-Gynecologist, 24(3), 71-76.Sacks G.P., et al. The role of complement in obstetric APS // Placenta. — 2014. — Vol. 35, No. 11. — P. 1–8.
Schreiber K., Hunt B.J. Managing antiphospholipid syndrome in pregnancy // Thrombosis Research. — 2019. — Vol. 181, Suppl. 1. — P.41–46.
Zaripova D.Ya., Abdullaeva M.A., Sultonova N.A., Ahmedov F.K., Nasirova Z.S., Umurov E.U., Shukrullaeva G.Zh. Optimizaciya mer diagnostiki rannej menopauzy i prezhdevremennoj menopauzy. Zhuranl Reproduktivnoe zdorov'e vo stochnaya Evropa. 2024;14 (5). S.617-628.
Tong M., et al. Trophoblast dysfunction and apoptosis associated with aPL // Hum Reprod Update. 2017. Vol. 21. P. 97–118.
Viall C.A., Chamley L.W. Placental infarction and impaired spiral artery remodeling in APS // Autoimmun Rev. 2019. Vol. 14. P. 446–471.
Zaripova, D.Ya., Abdullayeva, M. A., Sultanova, N. A., Akhmedov, F. K., Nasirov, Z. S., Umarov, E. U., & Shukrullayeva, G. J. (2024). Optimization of diagnostic measures for early menopause and premature menopause. The journal" Reproductive Health of Eastern Europe, 14(5), 617-628.
Willis R., et al. Pathophysiology of the antiphospholipid antibody syndrome // Autoimmunity Highlights. — 2021. — Vol. 2, No. 2. — P. 203-210.
